Secondcell Bio
Our innovation started out as an idea to automate and improve the system. Over 25 years, we have brought the method to work in practice, in the laboratory.
Now successfully commercially validated in diverse businesses and fields of use, including previously out-of-reach goals like discovery of the non-addictive pain blocker, the technology opens the floodgates to usher in an era of accelerated drug discovery.
From invention at The Rockefeller University to IPO at New York Stock Exchange to scale-up drug discovery for jointly owned Made-in-Abu-Dhabi Intellectual Property (IP) in the UAE, Dr. Kambiz Shekdar, PhD is the first U.S. Biotech Abu Dhabi Golden Visa Inventor transitioning to the UAE.
Dr. Kambiz Shekdar, PhD invented Chromovert® Technology while he was a graduate student in the laboratory of his mentor, the late Nobel laureate & King Faisal Prize winner Dr. Gunter Blobel, MD, PhD. at The Rockefeller University in New York City.
For more than 20 years, Dr. Shekdar has been pursuing applications of the same platform technology, now including pursuing the creation of a joint venture with Emirati stakeholders to implement the by-now validated research engine as part of a public-private partnership for drug discovery at scale in the UAE. Secondcell Bio is a member of the Abu Dhabi, UAE chapter of American Chambers of Commerce. Dr. Shekdar is Founding Chairman of the AmCham Abu Dhabi BioTech Committee and President of Research Foundation for Cure Initiatives.
